RightFit
RecruitingPhase not listed

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tracks how safe GPP drugs are and how well they work. It is for adults with generalized pustular psoriasis (GPP), a skin disease that causes pus-filled bumps, who are under a skin care provider’s care.

Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Have GPP diagnosed by a skin doctor or another qualified skin care provider.
  • Be at least 18 and old enough under local law to agree to the study procedures.
  • Be willing to agree to join the registry.
  • Be willing to share personal information.

Who can't join

  • Be in or plan to join a blinded trial of a drug that works throughout the body to treat or prevent GPP flare-ups. In a blinded trial, some people do not know which treatment is given.
  • Be enrolled in another CorEvitas registry for a skin condition. You must leave that registry before joining this one.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * A subject must meet all the following criteria to participate in the registry: 1. Has been diagnosed with GPP by a dermatologist or a qualified dermatology practitioner. 2. Is at least 18 years of age and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted. 3. Is willing to provide consent for participation in the registry. 4. Is willing to provide Personal Information Exclusion Criteria: * Any of the following would exclude the subject from participating in the registry: 1. Is participating or planning to participate in a blinded clinical trial evaluating a systemic agent for the treatment or prevention of flares related to GPP. 2. Is enrolled in another CorEvitas registry for a dermatological condition. Subjects enrolled in another CorEvitas registry must be exited to be eligible for enrollment into the GPP Registry

Study sites (1)

MA